Home > Insider Trading > Filing (0001144204-15-003359)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133869	Capricor Therapeutics Inc.	CAPR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1261186	J Louis Grasmick	C/O Capricor Therapeutics, Inc. 8840 Wilshire Blvd., 2Nd Floor Beverly Hills CA 90211		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-01-21	141,924	$3.52	1,039,436	No	4	P	Indirect	By Nancelou, Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Nancelou, Inc.

Footnotes

Nancelou, Inc. entered into a Share Purchase Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which Nancelou, Inc., on January 21, 2015, purchased an aggregate of 141,924 shares of the Issuer's common stock at a purchase price of $3.5230 per share for an aggregate purchase price of approximately US$500,000.
1,039,436 shares of the Issuer's common stock are beneficially owned by Nancelou, Inc. Louis Grasmick and Nancy Grasmick, husband and wife, own 50% of Nancelou, Inc. as tenants by the entirety, and Grant Grasmick, the son of Louis Grasmick and Nancy Grasmick, owns the remaining 50% of Nancelou, Inc. Therefore, Louis Grasmick, Nancy Grasmick and Grant Grasmick are deemed to have shared voting and dispositive power with respect to the securities of the Issuer beneficially owned by Nancelou, Inc.